Research Group Biobank (BB)

DZIF – German Center for Infection Research - Infrastructure Biobanking

Together with the BioMaterialBank Heidelberg (BMBH) we are responsible for the biobanking infrastructure within DZIF. The aim of the DZIF biobank is to provide secure, high quality, authenticated, and standardized biomaterials for DZIF projects and outside partners. Within the Infrastructure the Heidelberg site is responsible for coordination and tissue biobanking, whereas we focus on liquid biomaterials.

At present our main effort is the Transplantation (Tx) cohort of the Translational Unit “Infections in the immunocompromised host”, where we support in ELSI and data management questions and work to establish a quality management system with internal audits. We work towards harmonization and standardization of these topics at all DZIF partner sites and with cooperation partners. For the Munich Tx partners we store the biosamples centrally at HMGU biobank. An important task of our group is the operation of the central biosample registry (ZBR), which provides an up-to-date overview of available biosamples within DZIF.

DZHK – German Center for Cardiovascular Research: Scientific infrastructure project "Support of the DZHK in the Field of Ethics and Data Security"

Main objectives of the "Ethics projects" are the support of DZHK funded studies in all aspects of ethical questions in the context of the scientific infrastructure of the DZHK and the collaboration with the trusted third party to enable a smooth implementation of consent forms into the IT-system. We developed the "ethics concept for clinical research of the DZHK" including modular templates for informed consent (IC) for all DZHK clinical studies. To integrate these templates in the clinical research infrastructure and to facilitate the backtracking of contents a detailed information retrieval system was designed.

IC-templates are provided as broad consent to allow for an open and regulated access to data and biomaterials of the DZHK but need to get individualized for every study.

We perform training of the staff responsible for informed consent procedures at the study sites.

For all these tasks we work in close collaboration with the trusted third party, the transfer office and other components of the central data management of the DZHK.

Furthermore, we are part of the working groups IT and biobanking, clinical research and the project group e-health.

DZD – German Center for Diabetes Research

The DZD brings together experts in the field of diabetes research and combines basic research, translational research, epidemiology, and clinical applications.

Biosamples such as blood, tissue, or urine are indispensable in biomedical diabetes research, for example to find new biomarkers for earlier and better diagnosis. In the clinical studies, the DZD collects human biomaterials for the DZD Biobank.

We provide storage facilities and data management solutions for the biosamples collected for the DZD biobank.


BBMRI-LPC (Biobanking and Biomolecular Resources Research Infrastructure – Large Prospective Cohorts) is one of the largest biobanking networks in Europe. Its aim is to facilitate scientists’ access to large prospective study sets on human health and disease.

To this end, three scientific calls for proposals have been conducted. 12 access projects have been selected in a peer-reviewed process and researchers got access to the samples and data of participating cohorts and to a limited extent to metabolomics analysis, genotyping and sequencing.

Together with the Institute for Medical Statistics and Epidemiology at the Technical University Munich we are involved in translational access provision and determination of costs related to access to large prospective cohorts.

Furthermore, metabolomics and genotyping analysis for selected access projects are performed in AME.

See also


German Biobank Alliance: Connecting Biobanks, Enabling better Research, Engaging the Community

The German Biobank Node (GBN) is a German biobank network consisting of eleven large university biobank sites. Under the umbrella of GBN, all biobank partners work together in the German Biobank Alliance (GBA; see also to support biomedical research with high-quality biomaterial samples and data. HMGU Biobank is a partner in this alliance.
Together, they develop uniform quality standards, establish a networked IT structure and create legal and ethical guidelines for biobanking. In this way, they lay the foundation for the further development and quality assurance of biobanking in Germany and Europe. The Federal Ministry of Education and Research (BMBF) funds the network.
GBN also continues to be a partner in the European biobank network BBMRI-ERIC, which focuses on the networking and exchange of experience of biobanks within Europe.

GBA film

m4 Biobank Alliance / Joint Biobank Munich

The m4 Biobank Alliance / Joint Biobank Munich was part of the excellence cluster m4 Personalized Medicine and Targeted Therapies running in Munich from 2010 to 2015. Within the m4 Biobank Alliance, AME was responsible for harmonized and standardized collection, processing and storage of blood, blood derivatives, and urine samples (incl. SOPs) at the involved biobanks as well as for the quality management of liquid biosamples including internal audits at the partner sites. Moreover, we implemented quality documents such as the quality manual and established a quality management system for the m4 Service Unit as basis for a certification in accordance to DIN EN ISO 9001:2008.

We additionally provided help in IT, ethical and data security questions and initiated the preparation of a generic ethics and data protection concept for Munich. This included templates for informed consent and patient information and has been used as blueprint for DZG- and other biobanks.